公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2006 | Rapid and selective isolation of β-xylosidase through an activitybased chemical approach | Lo L.-C.; Chu C.-Y.; Pan Y.-R.; Wan C.-F.; Li Y.-K.; JING-JER LIN | Biotechnology Journal | 8 | 0 | |
1990 | Reconstitution of nucleotide excision nuclease with UvrA and UvrB proteins from Escherichia coli and UvrC protein from Bacillus subtilis | JING-JER LIN ; Sancar A. | Journal of Biological Chemistry | 29 | | |
2001 | Renaturation and stabilization of the telomere-binding activity of Saccharomyces Cdc13(451-693)p by L-arginine | Lin Y.-C.; Shih J.-W.; Hsu C.-L.; JING-JER LIN | Analytical Biochemistry | 6 | 3 | |
2023 | Response to Lehrer and Rheinstein | Lu, Kai; JING-JER LIN | Journal of the National Cancer Institute | | | |
1996 | The Saccharomyces CDC13 protein is a single-strand TG1-3 telomeric DNA-binding protein in vitro that affects telomere behavior in vivo | JING-JER LIN ; Zakian V.A. | Proceedings of the National Academy of Sciences of the United States of America | 278 | 280 | |
2010 | Selective activation of SHP2 activity by cisplatin revealed by a novel chemical probe-based assay | Kuo C.-C.; Chu C.-Y.; JING-JER LIN ; Lo L.-C. | Biochemical and Biophysical Research Communications | 9 | 10 | |
2009 | Sequential loading of Saccharomyces cerevisiae Ku and Cdc13p to telomeres | Wu T.-J.; Chiang Y.-H.; Lin Y.-C.; Tsai C.-R.; Yu T.-Y.; Sung M.-T.; Lee Y.-H.W.; JING-JER LIN | Journal of Biological Chemistry | 7 | 7 | |
2022 | Sequential Phosphorylation of Hepatitis C Virus NS5A Protein Requires the ATP-Binding Domain of NS3 Helicase | Yu, Chun-Chiao; Lin, Pei-Chen; Chiang, Cho-Han; Jen, Shu-Tang; Lai, Yen-Ling; Hsu, Shih-Chin; Lo, Lee-Chiang; JING-JER LIN ; NEI-LI CHAN ; MING-JIUN YU | Journal of virology | 2 | 2 | |
2017 | The serine protease inhibitor serpinB2 binds and stabilizes p21 in senescent cells | Hsieh H.-H.; Chen Y.-C.; Jhan J.-R.; JING-JER LIN | Journal of Cell Science | 25 | 27 | |
2001 | Specific Binding of Single-stranded Telomeric DNA by Cdc13p of Saccharomyces cerevisiae | Lin Y.-C.; Hsu C.-L.; Shih J.-W.; JING-JER LIN | Journal of Biological Chemistry | 19 | 19 | |
2011 | Structural bases of dimerization of yeast telomere protein Cdc13 and its interaction with the catalytic subunit of DNA polymerase α | Sun J.; Yang Y.; Wan K.; Mao N.; Yu T.-Y.; Lin Y.-C.; Dezwaan D.C.; Freeman B.C.; JING-JER LIN ; Lue N.F.; Lei M. | Cell Research | 60 | 58 | |
2013 | Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents | Chen T.-C.; Yu D.-S.; Huang K.-F.; Fu Y.-C.; Lee C.-C.; Chen C.-L.; Huang F.-C.; Hsieh H.-H.; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 26 | 24 | |
2013 | Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology | Chen C.-L.; Chang D.-M.; Chen T.-C.; Lee C.-C.; Hsieh H.-H.; Huang F.-C.; Huang K.-F.; JIH-HWA GUH ; JING-JER LIN ; Huang H.-S. | European Journal of Medicinal Chemistry | 35 | 34 | |
2001 | Studies on anthracenes. 1. Human telomerase inhibition and lipid peroxidation of 9-acyloxy 1,5-dichloroanthracene derivatives | Huang H.-S.; Hwang J.-M.; Jen Y.-M.; JING-JER LIN ; Lee K.-Y.; Shi C.-H.; Hsu H.-C. | Chemical and Pharmaceutical Bulletin | 26 | 22 | |
2005 | Study of the preferred modification sites of the quinone methide intermediate resulting from the latent trapping device of the activity probes for hydrolases | Lo, Lee-Chiang; Chiang, Ying-Ling; Kuo, Chi-Hsien; Liao, Hsin-Kai; Chen, Yu-Ju; Lin, Jing-Jer; JING-JER LIN ; LEE-CHIANG LO | Biochemical & Biophysical Research Communications | 30 | 28 | |
2023 | Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer | Lu, Kai; Wang, Hsin-Chiao; Tu, Yi-Chen; Chang, Cheng-Chung; PEI-JEN LOU ; Chang, Ta-Chau; JING-JER LIN | Journal of the National Cancer Institute | 2 | | |
2019 | Synthesis and biological evaluation of anthra[1,9-cd]pyrazol-6(2H)-one scaffold derivatives as potential anticancer agents | Chen T.-C.; JIH-HWA GUH ; Hsu H.-W.; Chen C.-L.; Lee C.-C.; Wu C.-L.; Lee Y.-R.; JING-JER LIN ; Yu D.-S.; Huang H.-S. | Arabian Journal of Chemistry | 8 | 7 | |
2009 | Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones | Shchekotikhin A.E.; Glazunova V.A.; Dezhenkova L.G.; Luzikov Y.N.; Sinkevich Y.B.; Kovalenko L.V.; Buyanov V.N.; Balzarini J.; Huang F.-C.; JING-JER LIN ; Huang H.-S.; Shtil A.A.; Preobrazhenskaya M.N. | Bioorganic and Medicinal Chemistry | 42 | 37 | |
2013 | Synthesis and evaluation of activity-based probes carrying a 5′-fluorosulfonylbenzoyl adenosine moiety for protein kinases | Hsu Y.-L.; Yang C.-C.; Lan C.-Y.; JING-JER LIN ; Lo L.-C. | Journal of the Chinese Chemical Society | 6 | 6 | |
2007 | Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones | Huang H.-S.; Chen I.-B.; Huang K.-F.; Lu W.-C.; Shieh F.-Y.; Huang Y.-Y.; Huang F.-C.; JING-JER LIN | Chemical and Pharmaceutical Bulletin | 48 | 44 | |